Bristol-Myers Squibb Co. Stock Prediction
AI-powered sentiment analysis and prediction trends for BMY, updated each market day.
BMY AI Sentiment
AI sees no strong directional signal for Bristol-Myers Squibb Co. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Sector
Exchange
Market Cap
$121,422,007,508
Cap Tier
Employees
32,500
Headquarters
PRINCETON, NJ
Listed Since
June 23, 1952
Website
BMY Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BMY Volatility
Bristol-Myers Squibb Co. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
